niacinamide has been researched along with B16 Melanoma in 19 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " nicotinamide, isonicotinamide or nicotinic acid, as extra (axial) ligands, were tested in vivo on transplanted mice tumors, namely Lewis lung carcinoma (3LL), melanoma B16, and mammary adenocarcinoma Ca755." | 3.72 | Selectivity of effects of redox-active cobalt(III) complexes on tumor tissue. ( Bubnovskaya, L; Campanella, L; Ganusevich, I; Kovelskaya, A; Levitin, I; Osinsky, S; Sigan, A; Valkovskaya, N; Wardman, P, 2004) |
| "Sorafenib is a multikinase inhibitor that induces apoptosis of melanoma cells in vitro." | 1.43 | Convection-enhanced delivery of sorafenib and suppression of tumor progression in a murine model of brain melanoma through the inhibition of signal transducer and activator of transcription 3. ( Brandon, VL; Chen, MY; Hsu, LC; Jandial, R; Jove, R; Li, G; Lin, J; Yang, F; Yin, Y; Zou, Z, 2016) |
| "Melanoma is highly metastatic, but the mechanism of melanoma cell migration is still unclear." | 1.40 | SIRT1 regulates lamellipodium extension and migration of melanoma cells. ( Hayashi, T; Hirobe, T; Hisahara, S; Horimoto, K; Horio, Y; Jimbow, K; Kunimoto, R; Sato, M; Sugino, T; Tanimura, A; Yamashita, T, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 12 (63.16) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Vale, JAD | 1 |
| de Souza, APM | 1 |
| Lima, GDA | 2 |
| Gonçalves, VHS | 2 |
| Moreira, GA | 2 |
| Barros, MVA | 2 |
| Pereira, WL | 1 |
| Merchid, NCLE | 1 |
| Fietto, JLR | 2 |
| Bressan, GC | 2 |
| Teixeira, RR | 2 |
| Machado-Neves, M | 2 |
| Chen, CC | 1 |
| Chen, YY | 1 |
| Lo, YH | 2 |
| Lin, MH | 2 |
| Chang, CH | 1 |
| Chen, CL | 2 |
| Wang, HE | 2 |
| Wu, CY | 2 |
| Scatozza, F | 1 |
| Moschella, F | 1 |
| D'Arcangelo, D | 1 |
| Rossi, S | 1 |
| Tabolacci, C | 1 |
| Giampietri, C | 1 |
| Proietti, E | 1 |
| Facchiano, F | 1 |
| Facchiano, A | 1 |
| Chang, TY | 1 |
| Chang, CW | 1 |
| Liu, RS | 1 |
| Seddik, U | 1 |
| Aglan, H | 1 |
| Trencsényi, G | 1 |
| Szabó, JP | 1 |
| Kertész, I | 1 |
| Kandil, SA | 1 |
| Siqueira, RP | 1 |
| Adjanohoun, ALM | 1 |
| Santos, VC | 1 |
| Barbosa, ÉAA | 1 |
| Loterio, RK | 1 |
| Paiva, JC | 1 |
| Viol, LCS | 1 |
| Marques-da-Silva, EA | 1 |
| Júnior, AS | 1 |
| Almeida, MR | 1 |
| Ferreira, RS | 1 |
| Kunimoto, R | 1 |
| Jimbow, K | 1 |
| Tanimura, A | 1 |
| Sato, M | 1 |
| Horimoto, K | 1 |
| Hayashi, T | 1 |
| Hisahara, S | 1 |
| Sugino, T | 1 |
| Hirobe, T | 1 |
| Yamashita, T | 1 |
| Horio, Y | 1 |
| Toledo, M | 1 |
| Penna, F | 1 |
| Busquets, S | 1 |
| López-Soriano, FJ | 1 |
| Argilés, JM | 1 |
| Zou, Z | 1 |
| Yin, Y | 1 |
| Lin, J | 1 |
| Hsu, LC | 1 |
| Brandon, VL | 1 |
| Yang, F | 1 |
| Jove, R | 1 |
| Jandial, R | 1 |
| Li, G | 1 |
| Chen, MY | 1 |
| Kim, B | 2 |
| Hwang, JS | 1 |
| Kim, HS | 1 |
| Laurila, JP | 1 |
| Laukkanen, MO | 1 |
| Joensuu, H | 1 |
| Salmi, M | 1 |
| Jalkanen, S | 1 |
| Liu, X | 1 |
| Pham, TQ | 1 |
| Berghofer, P | 1 |
| Chapman, J | 1 |
| Greguric, I | 1 |
| Mitchell, P | 1 |
| Mattner, F | 1 |
| Loc'h, C | 1 |
| Katsifis, A | 1 |
| Tsai, JH | 1 |
| Lee, WM | 1 |
| Masunaga, S | 2 |
| Matsumoto, Y | 1 |
| Kashino, G | 1 |
| Hirayama, R | 1 |
| Liu, Y | 2 |
| Tanaka, H | 2 |
| Sakurai, Y | 2 |
| Suzuki, M | 2 |
| Kinashi, Y | 2 |
| Maruhashi, A | 2 |
| Ono, K | 2 |
| Leguerney, I | 1 |
| Lassau, N | 1 |
| Koscielny, S | 1 |
| Rodrigues, M | 1 |
| Massard, C | 1 |
| Rouffiac, V | 1 |
| Benatsou, B | 1 |
| Thalmensi, J | 1 |
| Bawa, O | 1 |
| Opolon, P | 1 |
| Peronneau, P | 1 |
| Roche, A | 1 |
| Kim, JE | 1 |
| Lee, SM | 1 |
| Lee, SH | 1 |
| Lee, JW | 1 |
| Kim, MK | 1 |
| Lee, KJ | 1 |
| Kim, H | 1 |
| Lee, JD | 1 |
| Choi, KY | 1 |
| Kondo, N | 1 |
| Rbah-Vidal, L | 1 |
| Vidal, A | 1 |
| Besse, S | 1 |
| Cachin, F | 1 |
| Bonnet, M | 1 |
| Audin, L | 1 |
| Askienazy, S | 1 |
| Dollé, F | 1 |
| Degoul, F | 1 |
| Miot-Noirault, E | 1 |
| Moins, N | 1 |
| Auzeloux, P | 1 |
| Chezal, JM | 1 |
| Osinsky, S | 1 |
| Levitin, I | 1 |
| Bubnovskaya, L | 1 |
| Sigan, A | 1 |
| Ganusevich, I | 1 |
| Kovelskaya, A | 1 |
| Valkovskaya, N | 1 |
| Campanella, L | 1 |
| Wardman, P | 1 |
1 trial available for niacinamide and B16 Melanoma
| Article | Year |
|---|---|
N-Nicotinoyl dopamine, a novel niacinamide derivative, retains high antioxidant activity and inhibits skin pigmentation.
Topics: Animals; Antioxidants; Bleaching Agents; Cell Line; Cell Line, Tumor; Dopamine; Humans; Hyperpigment | 2011 |
18 other studies available for niacinamide and B16 Melanoma
| Article | Year |
|---|---|
Effect of the topical administration of N-(2-(4-bromophenylamino)-5-(trifluoromethyl)phenyl)nicotinamide compound in a murine subcutaneous melanoma model.
Topics: Administration, Topical; Animals; Caspase 3; Cell Death; Male; Melanoma, Experimental; Mice; Mice, I | 2020 |
Evaluation of Radioiodinated Fluoronicotinamide/Fluoropicolinamide-Benzamide Derivatives as Theranostic Agents for Melanoma.
Topics: Animals; Benzamides; Cell Line, Tumor; Humans; Iodine Radioisotopes; Melanins; Melanoma, Experimenta | 2020 |
Nicotinamide inhibits melanoma in vitro and in vivo.
Topics: Aged; Animals; Apoptosis; Cell Cycle; Cell Proliferation; Female; Humans; In Vitro Techniques; Male; | 2020 |
Development of Radiofluorinated Nicotinamide/Picolinamide Derivatives as Diagnostic Probes for the Detection of Melanoma.
Topics: Animals; Cell Line, Tumor; Fluorine Radioisotopes; Melanins; Melanoma, Experimental; Mice; Niacinami | 2021 |
Rapid radiosynthesis of two [
Topics: Animals; Carbon-13 Magnetic Resonance Spectroscopy; Cell Line, Tumor; Chromatography, High Pressure | 2018 |
Antimetastatic effect of the pharmacological inhibition of serine/arginine-rich protein kinases (SRPK) in murine melanoma.
Topics: Animals; Antineoplastic Agents; Cell Adhesion; Cell Movement; Drug Screening Assays, Antitumor; Fema | 2018 |
SIRT1 regulates lamellipodium extension and migration of melanoma cells.
Topics: Animals; Cell Movement; Female; Gene Expression Regulation, Neoplastic; Melanoma; Melanoma, Experime | 2014 |
Distinct behaviour of sorafenib in experimental cachexia-inducing tumours: the role of STAT3.
Topics: Animals; Antineoplastic Agents; Cachexia; Carcinoma, Lewis Lung; Colon; Colonic Neoplasms; Lung; Mel | 2014 |
Convection-enhanced delivery of sorafenib and suppression of tumor progression in a murine model of brain melanoma through the inhibition of signal transducer and activator of transcription 3.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Convection; Heterografts; Humans; | 2016 |
N-Nicotinoyl dopamine inhibits skin pigmentation by suppressing of melanosome transfer.
Topics: Animals; Biological Transport; Coculture Techniques; Dopamine; Gene Expression Regulation, Enzymolog | 2015 |
Leukocyte trafficking is not affected by multikinase inhibitors sunitinib or sorafenib in mice.
Topics: Animals; Cell Movement; Female; Indoles; Leukocytes; Melanoma, Experimental; Mice; Mice, Inbred BALB | 2016 |
Synthesis and evaluation of novel radioiodinated nicotinamides for malignant melanoma.
Topics: Animals; Female; Iodine Radioisotopes; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbr | 2008 |
Tie2 in tumor endothelial signaling and survival: implications for antiangiogenic therapy.
Topics: Angiopoietin-1; Animals; Apoptosis; Benzenesulfonates; Doxycycline; Endothelial Cells; Enzyme Activa | 2009 |
Significance of manipulating tumour hypoxia and radiation dose rate in terms of local tumour response and lung metastatic potential, referring to the response of quiescent cell populations.
Topics: Animals; Bromodeoxyuridine; Cell Hypoxia; Combined Modality Therapy; Female; Gamma Rays; Lung Neopla | 2010 |
Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemoth | 2012 |
Effects of employing a ¹⁰B-carrier and manipulating intratumour hypoxia on local tumour response and lung metastatic potential in boron neutron capture therapy.
Topics: Animals; Antineoplastic Agents; Borohydrides; Boron Neutron Capture Therapy; Bromodeoxyuridine; Cell | 2012 |
Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer.
Topics: Animals; Biological Transport; Early Detection of Cancer; Longitudinal Studies; Male; Melanoma, Expe | 2012 |
Selectivity of effects of redox-active cobalt(III) complexes on tumor tissue.
Topics: Adenocarcinoma; Animals; Carcinoma, Lewis Lung; Cobalt; DNA Damage; Ethylenediamines; Female; Hypoxi | 2004 |